Naoki Agata

1.6k total citations
28 papers, 1.3k citations indexed

About

Naoki Agata is a scholar working on Molecular Biology, Cancer Research and Oncology. According to data from OpenAlex, Naoki Agata has authored 28 papers receiving a total of 1.3k indexed citations (citations by other indexed papers that have themselves been cited), including 18 papers in Molecular Biology, 10 papers in Cancer Research and 6 papers in Oncology. Recurrent topics in Naoki Agata's work include Synthesis and Biological Activity (5 papers), Renal cell carcinoma treatment (3 papers) and Angiogenesis and VEGF in Cancer (3 papers). Naoki Agata is often cited by papers focused on Synthesis and Biological Activity (5 papers), Renal cell carcinoma treatment (3 papers) and Angiogenesis and VEGF in Cancer (3 papers). Naoki Agata collaborates with scholars based in Japan, United States and United Kingdom. Naoki Agata's co-authors include Donald Küfe, Surender Kharbanda, Deepak Raina, Lei Huang, Takeshi Kawano, Yongqing Li, Wei‐Hsuan Yu, Dongshu Chen, Wen Chen and Jian Ren and has published in prestigious journals such as Cell, Journal of Clinical Oncology and Cancer Cell.

In The Last Decade

Naoki Agata

28 papers receiving 1.3k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Naoki Agata Japan 16 772 354 294 245 229 28 1.3k
Kiyoshi Okamoto Japan 15 611 0.8× 514 1.5× 267 0.9× 331 1.4× 100 0.4× 55 1.7k
Haruhiko Makino Japan 20 431 0.6× 673 1.9× 129 0.4× 345 1.4× 223 1.0× 83 1.6k
Akintunde Akinleye United States 11 660 0.9× 742 2.1× 164 0.6× 224 0.9× 343 1.5× 13 1.5k
Ann M. McNulty United States 18 975 1.3× 435 1.2× 228 0.8× 452 1.8× 86 0.4× 33 1.7k
Thomas C. Caffrey United States 21 1000 1.3× 507 1.4× 263 0.9× 109 0.4× 375 1.6× 36 1.5k
Raffaele Longo Italy 19 567 0.7× 571 1.6× 326 1.1× 297 1.2× 73 0.3× 64 1.5k
Alessandra Leone Italy 22 934 1.2× 412 1.2× 312 1.1× 212 0.9× 109 0.5× 38 1.4k
Francesca Bruzzese Italy 24 1.2k 1.5× 593 1.7× 308 1.0× 293 1.2× 116 0.5× 55 1.7k
Hisao Fukumoto Japan 17 587 0.8× 432 1.2× 129 0.4× 193 0.8× 53 0.2× 30 1.0k
Yuning Liao China 25 1.1k 1.5× 455 1.3× 253 0.9× 279 1.1× 108 0.5× 58 1.6k

Countries citing papers authored by Naoki Agata

Since Specialization
Citations

This map shows the geographic impact of Naoki Agata's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Naoki Agata with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Naoki Agata more than expected).

Fields of papers citing papers by Naoki Agata

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Naoki Agata. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Naoki Agata. The network helps show where Naoki Agata may publish in the future.

Co-authorship network of co-authors of Naoki Agata

This figure shows the co-authorship network connecting the top 25 collaborators of Naoki Agata. A scholar is included among the top collaborators of Naoki Agata based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Naoki Agata. Naoki Agata is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Takeuchi, Tsutomu, Ryo Nakajima, Shuichi Komatsu, et al.. (2017). Impact of Adalimumab on Work Productivity and Activity Impairment in Japanese Patients with Rheumatoid Arthritis: Large-Scale, Prospective, Single-Cohort ANOUVEAU Study. Advances in Therapy. 34(3). 686–702. 20 indexed citations
2.
Tanaka, Yoshiya, Hisashi Yamanaka, Naoki Ishiguro, et al.. (2017). Low disease activity for up to 3 years after adalimumab discontinuation in patients with early rheumatoid arthritis: 2-year results of the HOPEFUL-3 Study. Arthritis Research & Therapy. 19(1). 56–56. 14 indexed citations
3.
4.
Tomita, Yoshihiko, Nobuo Shinohara, Takeshi Yuasa, et al.. (2010). Overall Survival and Updated Results from a Phase II Study of Sunitinib in Japanese Patients with Metastatic Renal Cell Carcinoma. Japanese Journal of Clinical Oncology. 40(12). 1166–1172. 100 indexed citations
5.
Uemura, Hirotsugu, Nozomi Shinohara, Takeshi Yuasa, et al.. (2009). A Phase II Study of Sunitinib in Japanese Patients with Metastatic Renal Cell Carcinoma: Insights into the Treatment, Efficacy and Safety. Japanese Journal of Clinical Oncology. 40(3). 194–202. 119 indexed citations
6.
Agata, Naoki, Rehan Ahmad, Takeshi Kawano, et al.. (2008). MUC1 Oncoprotein Blocks Death Receptor–Mediated Apoptosis by Inhibiting Recruitment of Caspase-8. Cancer Research. 68(15). 6136–6144. 75 indexed citations
7.
Ueki, Yasuyoshi, Chin‐Yu Lin, Makoto Senoo, et al.. (2007). Increased Myeloid Cell Responses to M-CSF and RANKL Cause Bone Loss and Inflammation in SH3BP2 “Cherubism” Mice. Cell. 128(1). 71–83. 137 indexed citations
8.
Kawano, Takeshi, Naoki Agata, Surender Kharbanda, David Avigan, & Donald Küfe. (2006). A novel isocoumarin derivative induces mitotic phase arrest and apoptosis of human multiple myeloma cells. Cancer Chemotherapy and Pharmacology. 59(3). 329–335. 47 indexed citations
9.
Ichinose, Kunihiro, Yohei Maeshima, Yoshihiko Yamamoto, et al.. (2006). 2-(8-Hydroxy-6-Methoxy-1-Oxo-1H-2-Benzopyran-3-yl) Propionic Acid, an Inhibitor of Angiogenesis, Ameliorates Renal Alterations in Obese Type 2 Diabetic Mice. Diabetes. 55(5). 1232–1242. 71 indexed citations
10.
Agata, Naoki, Hiroko Nogi, Michael Bamberg, et al.. (2005). The angiogenesis inhibitor NM-3 is active against human NSCLC xenografts alone and in combination with docetaxel. Cancer Chemotherapy and Pharmacology. 56(6). 610–614. 6 indexed citations
11.
Kumagai, Hiroyuki, Kuniko Wakazono, Naoki Agata, et al.. (2005). Effect of Cytogenin, a Novel Immunomodulator, on Streptozotocin-induced Diabetes in Mice. The Journal of Antibiotics. 58(3). 202–205. 5 indexed citations
12.
Ren, Jian, Naoki Agata, Dongshu Chen, et al.. (2004). Human MUC1 carcinoma-associated protein confers resistance to genotoxic anticancer agents. Cancer Cell. 5(2). 163–175. 282 indexed citations
13.
Reimer, Corinne, Naoki Agata, Jennifer Tammam, et al.. (2002). Antineoplastic effects of chemotherapeutic agents are potentiated by NM-3, an inhibitor of angiogenesis.. PubMed. 62(3). 789–95. 42 indexed citations
14.
Matsumoto, Naoki, H. Nakamura, Naoki Agata, et al.. (2000). Synthesis of NF-κB activation inhibitors derived from epoxyquinomicin C. Bioorganic & Medicinal Chemistry Letters. 10(9). 865–869. 148 indexed citations
15.
Fujii, Tadashi, et al.. (2000). Characterization of L-Lysine 6-Aminotransferase and Its Structural Gene from Flavobacterium lutescens IFO3084. The Journal of Biochemistry. 128(3). 391–397. 31 indexed citations
16.
Matsumoto, Naoki, et al.. (2000). Inhibition of Rat Embryo Histidine Decarboxylase by Epoxyquinomicins.. The Journal of Antibiotics. 53(6). 637–639. 5 indexed citations
17.
Fujii, Tadashi, et al.. (2000). Cloning and Characterization of pcd Encoding  '-Piperideine-6-Carboxylate Dehydrogenase from Flavobacterium lutescens IFO3084. The Journal of Biochemistry. 128(6). 975–982. 12 indexed citations
18.
NAKADE, Tetsuya, Hiroshi Yokota, Hiroyuki TANIYAMA, et al.. (2000). Matrix metalloproteinase (MMP) 9 induced in skin and subcutaneous tissue by implanted chitin in rats. Carbohydrate Polymers. 41(4). 327–329. 6 indexed citations
19.
C, Abe, Shin‐ichi Hirano, Toshiyasu Mase, et al.. (1995). Effects of cytogenin on spontaneous arthritis in MRL/1 mice and on pristane-induced arthritis (PIA) in DBA/1J mice.. PubMed. 17(5-6). 175–80. 4 indexed citations
20.
Agata, Naoki, et al.. (1991). A COMPARISON OF PIRARUBICIN WITH OTHER ANAHRACYCLINES ON THE CARDIOVASCULAR SYSTEM. 41(5). 467–474. 5 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Kiyoshi Okamoto Breakdown of academic impact, for papers by Haruhiko Makino Breakdown of academic impact, for papers by Akintunde Akinleye Breakdown of academic impact, for papers by Ann M. McNulty Breakdown of academic impact, for papers by Thomas C. Caffrey Breakdown of academic impact, for papers by Raffaele Longo Breakdown of academic impact, for papers by Alessandra Leone Breakdown of academic impact, for papers by Francesca Bruzzese Breakdown of academic impact, for papers by Hisao Fukumoto Breakdown of academic impact, for papers by Yuning Liao
Rankless by CCL
2026